RPG Investment Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

RPG Investment Advisory’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.67M	Sell	23,196 -39	-0.2%	-$5.27K	0.38%	51
2026 Q1	$2.97M	Sell	23,235 -230	-1%	-$28.7K	0.36%	51
2025 Q4	$2.86M	Sell	23,465 -128	-0.5%	-$14.7K	0.32%	52
2025 Q3	$2.36M	Sell	23,593 -686	-3%	-$61.8K	0.28%	51
2025 Q2	$2.01M	Sell	24,279 -26,461	-52%	-$2.11M	0.25%	51
2025 Q1	$4.12M	Buy	50,740 +25,109	+98%	+$2.24M	0.29%	51
2024 Q4	$2.31M	Sell	25,631 -668	-3%	-$64.7K	0.31%	55
2024 Q3	$2.6M	Sell	26,299 -414	-2%	-$40.7K	0.37%	55
2024 Q2	$2.48M	Sell	26,713 -486	-2%	-$43.6K	0.37%	55
2024 Q1	$2.58M	Buy	27,199 +3,169	+13%	+$294K	0.39%	54
2023 Q4	$2.15M	Buy	24,030 +1,240	+5%	+$92.1K	0.35%	55
2023 Q3	$1.66M	Sell	22,790 -330	-1%	-$26.4K	0.31%	55
2023 Q2	$1.92M	Sell	23,120 -1,409	-6%	-$118K	0.33%	57
2023 Q1	$1.87M	Buy	24,529 +550	+2%	+$45.6K	0.33%	60
2022 Q4	$1.99M	Sell	23,979 -101	-0.4%	-$8.18K	0.38%	62
2022 Q3	$1.91M	Sell	24,080 -115	-0.5%	-$9.7K	0.41%	61
2022 Q2	$1.8M	Buy	24,195 +330	+1%	+$24.8K	0.36%	65
2022 Q1	$2.15M	Buy	23,865 +113	+0.5%	+$10.4K	0.35%	65
2021 Q4	$2.66M	Sell	23,752 -402	-2%	-$48.5K	0.41%	70
2021 Q3	$3.04M	Sell	24,154 -652	-3%	-$84K	0.5%	69
2021 Q2	$3.36M	Buy	24,806 +761	+3%	+$100K	0.55%	69
2021 Q1	$3.26M	Buy	24,045 +456	+2%	+$68.3K	0.58%	71
2020 Q4	$3.32M	Sell	23,589 -376	-2%	-$48.2K	0.67%	66
2020 Q3	$2.67M	Buy	23,965 +157	+0.7%	+$17.6K	0.65%	60
2020 Q2	$2.67M	Buy	23,808 +296	+1%	+$29.2K	0.7%	58
2020 Q1	$1.82M	Buy	23,512 +123	+0.5%	+$10.9K	0.52%	66
2019 Q4	$2.23M	Buy	23,389 +2,435	+12%	+$211K	0.51%	65
2019 Q3	$1.6M	Buy	20,954 +208	+1%	+$17.3K	0.38%	66
2019 Q2	$1.82M	Buy	20,746 +840	+4%	+$71.6K	0.43%	67
2019 Q1	$1.8M	Sell	19,906 -500	-2%	-$42.5K	0.42%	69
2018 Q4	$1.46M	Buy	20,406 +138	+0.7%	+$11.1K	0.37%	75
2018 Q3	$1.94M	Sell	20,268 -259	-1%	-$25.1K	0.41%	74
2018 Q2	$1.95M	Sell	20,527 -279	-1%	-$25.6K	0.44%	72
2018 Q1	$1.82M	Sell	20,806 -16,197	-44%	-$1.48M	0.42%	69
2017 Q4	$3.14M	Sell	37,003 -3,162	-8%	-$265K	0.76%	51
2017 Q3	$3.48M	Sell	40,165 -3,488	-8%	-$280K	0.89%	47
2017 Q2	$3.37M	Sell	43,653 -2,129	-5%	-$151K	0.92%	44
2017 Q1	$3.17M	Sell	45,782 -604	-1%	-$40.6K	0.93%	45
2016 Q4	$2.75M	Sell	46,386 -8,245	-15%	-$509K	0.93%	45
2016 Q3	$3.62M	Sell	54,631 -619	-1%	-$38.3K	1.13%	35
2016 Q2	$2.99M	Buy	55,250 +36,868	+201%	+$2.02M	0.8%	51
2016 Q1	$949K	Buy	18,382 +1,687	+10%	+$87.6K	0.37%	67
2015 Q4	$1.17M	Buy	+16,695	New	+$1.14M	0.44%	63

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

RPG Investment Advisory's XBI Position: Q2 2026 in Review

RPG Investment Advisory reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.17% in Q2 2026, selling an estimated $5.27K and leaving 23,196 shares worth $3.67M. The position accounts for 0.38% of the portfolio, ranked #51.

RPG Investment Advisory first reported a position in XBI in Q4 2015 and has held it in 43 quarters since. The position peaked at $4.12M in Q1 2025. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

RPG Investment Advisory held 23,196 shares of State Street SPDR S&P Biotech ETF worth $3.67M as of Q2 2026.
RPG Investment Advisory sold 39 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $5.27K.
State Street SPDR S&P Biotech ETF made up 0.38% of RPG Investment Advisory's portfolio in Q2 2026, its #51 holding.
RPG Investment Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q4 2015 and has held it in 43 quarters since.
RPG Investment Advisory's State Street SPDR S&P Biotech ETF position peaked at $4.12M in Q1 2025.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on RPG Investment Advisory's 13F filing for Q2 2026, filed 4 Aug 2026.